Author:
Knapskog Anne-Brita,Edwin Trine Holt,Ueland Per Magne,Ulvik Arve,Fang Evandro Fei,Eldholm Rannveig Sakshaug,Halaas Nathalie Bodd,Giil Lasse M.,Saltvedt Ingvild,Watne Leiv Otto,Aksnes Mari
Abstract
Abstract
Background
Sex differences in neuroinflammation could contribute to women’s increased risk of Alzheimer’s disease (AD), providing rationale for exploring sex-specific AD biomarkers. In AD, dysregulation of the kynurenine pathway (KP) contributes to neuroinflammation and there is some evidence of sex differences in KP metabolism. However, the sex-specific associations between KP metabolism and biomarkers of AD and neuroinflammation need to be explored further.
Methods
Here we investigate sex differences in cerebrospinal fluid concentrations of seven KP metabolites and sex-specific associations with established AD biomarkers and neopterin, an indicator of neuroinflammation. This study included 311 patients with symptomatic AD and 105 age-matched cognitively unimpaired (CU) controls, followed for up to 5 years.
Results
We found sex differences in KP metabolites in the AD group, with higher levels of most metabolites in men, while there were no sex differences in the CU group. In line with this, more KP metabolites were significantly altered in AD men compared to CU men, and there was a trend in the same direction in AD women. Furthermore, we found sex-specific associations between kynurenic acid and the kynurenic acid/quinolinic acid ratio with neopterin, but no sex differences in the associations between KP metabolites and clinical progression.
Discussion
In our cohort, sex differences in KP metabolites were restricted to AD patients. Our results suggest that dysregulation of the KP due to increased inflammation could contribute to higher AD risk in women.
Funder
Nasjonalforeningen for Folkehelsen,Norway
Wellcome Leap
Cure Alzheimer's Fund
Helse Sør-Øst RHF
Norges Forskningsråd
Norges Teknisk-Naturvitenskapelige Universitet
VitaDAO, Canada
NordForsk,Norway
National Natural Science Foundation of China
Akershus Universitetssykehus
Civitan Norges Forskningsfond for Alzheimers sykdom, Norway
Czech Republic-Norway KAPPA programme, Czech Republic
Kreftforeningen
University of Oslo
Publisher
Springer Science and Business Media LLC